puricore plc (PURI) Snapshot

PuriCore plc reported unaudited interim management statement for the first quarter ended March 31, 2013. Group revenue was down 23.7% (23.2% at constant currency) to $10.9 million against $14.3 million last year. EBITDA was profitable in Endoscopy and Wound Care businesses. Comparative revenue results, however, were affected by very high installations of Sterilox Fresh Systems during the first quarter of 2012 as well as the receipt of a $14 million Sterilox Fresh contract that was not signed and therefore not delivering revenue until second quarter of 2013. This agreement and other forthcoming orders in the Supermarket Retail business plus expansion into the floral departments will continue to drive revenues in the Supermarket Retail segment for the full year.

PuriCore plc announced the changes to the Board. Charles Spicer, a seasoned medical technology executive based in the UK, has been appointed Independent Non-Executive Director with effect from 1 June 2013. The company also announced that James Walsh, PhD, has elected to step down from the board effective from 27 June 2013 due to the increasing constraints on his time. Mr. Spicer has more than 15 years of experience working with the healthcare sector and specifically the medtech segment. Mr. Spicer is a Non-Executive Director of Aircraft Medical, Stanmore Implants, Ark Therapeutics Group plc, and XCounter AB. He is chair of the UK Department of Health's Invention for Innovation Funding Panel. Previously, Mr. Spicer served as chief executive and a Director of MDY Healthcare plc.

PuriCore plc reported consolidated earnings results for the year ended December 31, 2012. For the period, the company reported loss before taxation as $3,152,616 against $9,128,817 a year ago. Loss from continuing operations was $927,919 or $0.04 per basic and diluted share against $9,128,817 or $0.37 per basic and diluted share a year ago. Loss for the year attributable to equity holders of the parent was $927,919 against $9,128,817 a year ago. Purchase of property, plant and equipment was $1,126,197 against $656,100 a year ago. Purchase of intangible assets was $745,766.